Crispr injection could reduce chance of heart attack
Guardian - 10-May-2019Verve Therapeutics treatment targets PCSK9 gene
Join the club for FREE to access the whole archive and other member benefits.
University Lecturer in Cardiovascular Genetics at Oxford University.
Martin Farrall is a University Lecturer in Cardiovascular Genetics. He researches the genetic basis of common cardiovascular diseases such as coronary artery disease and high blood pressure. He also assists with the tutorial teaching of medical and physiology students (specifically teaching medical and molecular genetics).
He a genetic epidemiologist, a specialized branch of human genetics, in which they develop and apply statistical techniques to study the molecular and population genetics of inherited human diseases. They collaborate with UK and European academic groups to undertake large-scale genetic studies of common cardiovascular diseases and associated quantitative traits (so called "intermediate phenotypes"). These diseases have a multifactorial basis with numerous genetic and environmental causes - our task is to design experiments and analyse the data to reliably detect individual genetic effects.
Visit website: https://www.well.ox.ac.uk/people/martin-farrall
See also: University of Oxford - Collegiate research university and one of the world's leading universities
Details last updated 25-Dec-2019
Verve Therapeutics treatment targets PCSK9 gene